Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonard R DeRogatis

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
The Journal of Sexual Medicine|January 7, 2012
How to evaluate the efficacy of the phosphodiesterase type 5 inhibitorsEmmanuele A Jannini, Leonard R DeRogatis, Eric Chung, et al.
The Journal of Sexual Medicine|April 17, 2013
Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 2. For women with loss of subjective sexual arousalAnita H Clayton, Leonard R DeRogatis, Raymond C Rosen, et al.
The Journal of Sexual Medicine|July 14, 2012
Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 1. For women with incomplete loss of desire or sexual receptivityAnita H Clayton, Leonard R DeRogatis, Raymond C Rosen, et al.
The Journal of Sexual Medicine|October 17, 2016
Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part ILeonard R Derogatis, Michael Sand, Richard Balon, et al.
The Journal of Sexual Medicine|February 18, 2011
Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in womenLouis F Fabre, Candace S Brown, Louis C Smith, et al.
The Journal of Sexual Medicine|July 22, 2008
Sexual function, dysfunction, and sexual distress in a prospective, population-based sample of mid-aged, Australian-born womenLorraine Dennerstein, Janet R Guthrie, Richard D Hayes, et al.
The Journal of Sexual Medicine|January 21, 2006
Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies: a statement of concernStanley E Althof, John Dean, Leonard R Derogatis, et al.
The Journal of Sexual Medicine|May 21, 2011
Content validity of the Female Sexual Function Index (FSFI) in pre- and postmenopausal women with hypoactive sexual desire disorderDennis A Revicki, Mary K Margolis, Elizabeth N Bush, et al.
Menopause (New York, N.Y.)|November 6, 2019
Prevalence of depression and anxiety in women newly diagnosed with vulvovaginal atrophy and dyspareuniaErick Moyneur, Katherine Dea, Leonard R Derogatis, et al.
The Journal of Sexual Medicine|January 14, 2012
The effect of gepirone-ER in the treatment of sexual dysfunction in depressed menLouis F Fabre, Anita H Clayton, Louis C Smith, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Sexual Medicine|January 7, 2012
How to evaluate the efficacy of the phosphodiesterase type 5 inhibitorsEmmanuele A Jannini, Leonard R DeRogatis, Eric Chung, et al.
The Journal of Sexual Medicine|April 17, 2013
Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 2. For women with loss of subjective sexual arousalAnita H Clayton, Leonard R DeRogatis, Raymond C Rosen, et al.
The Journal of Sexual Medicine|July 14, 2012
Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 1. For women with incomplete loss of desire or sexual receptivityAnita H Clayton, Leonard R DeRogatis, Raymond C Rosen, et al.
The Journal of Sexual Medicine|October 17, 2016
Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part ILeonard R Derogatis, Michael Sand, Richard Balon, et al.
The Journal of Sexual Medicine|February 18, 2011
Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in womenLouis F Fabre, Candace S Brown, Louis C Smith, et al.
The Journal of Sexual Medicine|July 22, 2008
Sexual function, dysfunction, and sexual distress in a prospective, population-based sample of mid-aged, Australian-born womenLorraine Dennerstein, Janet R Guthrie, Richard D Hayes, et al.
The Journal of Sexual Medicine|January 21, 2006
Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies: a statement of concernStanley E Althof, John Dean, Leonard R Derogatis, et al.
The Journal of Sexual Medicine|May 21, 2011
Content validity of the Female Sexual Function Index (FSFI) in pre- and postmenopausal women with hypoactive sexual desire disorderDennis A Revicki, Mary K Margolis, Elizabeth N Bush, et al.
Menopause (New York, N.Y.)|November 6, 2019
Prevalence of depression and anxiety in women newly diagnosed with vulvovaginal atrophy and dyspareuniaErick Moyneur, Katherine Dea, Leonard R Derogatis, et al.
The Journal of Sexual Medicine|January 14, 2012
The effect of gepirone-ER in the treatment of sexual dysfunction in depressed menLouis F Fabre, Anita H Clayton, Louis C Smith, et al.
Pageof 5